Angela O. Shogbon

Outcomes and Characteristics of Patients with Potentially Inappropriate Classification of Clostridium Difficile Infection at a Community Hospital

J. Keum, Bobby Jacob, S. Peasah, 2017 .

A Comparison of Students’ Self-Assessments With Faculty Evaluations of Their Communication Skills

Angela O. Shogbon, K. Momary, L. Lundquist, 2013, American Journal of Pharmaceutical Education.

The Therapeutic Use of Vaptans for the Treatment of Dilutional Hyponatremia

Angela O. Shogbon, Maha Saad, M. Cassagnol, 2011, Journal of pharmacy practice.

First-year Student Pharmacists’ Spirituality and Perceptions Regarding the Role of Spirituality in Pharmacy Education

Bobby Jacob, Angela O. Shogbon, Annesha White, 2017, American Journal of Pharmaceutical Education.

Postoperative Pain Management With Liposomal Bupivacaine in Patients Undergoing Orthopedic Knee and Hip Arthroplasty at a Community Hospital

Bobby Jacob, S. Peasah, Angela O. Shogbon, 2017, Hospital pharmacy.

Student Pharmacists’ Clinical Interventions in Advanced Pharmacy Practice Experiences at a Community Nonteaching Hospital

Angela O. Shogbon, L. Lundquist, 2014, American Journal of Pharmaceutical Education.

Utilization of a structured approach to patient-based pharmacotherapy notes in a therapeutics course to improve clinical documentation skills

Angela O. Shogbon, K. Momary, L. Lundquist, 2016 .

Cryptogenic Organizing Pneumonia During Adjuvant Chemotherapy With Oxaliplatin, 5-Fluorouracil, and Leucovorin (FOLFOX) for Colon Cancer

Angela O. Shogbon, R. Dretler, A. Dalvi, 2013, Journal of pharmacy practice.

Intensive glucose control in the management of diabetes mellitus and inpatient hyperglycemia.

S. B. Levy, Angela O. Shogbon, 2010, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Nurses' perceptions and satisfaction with the use of insulin pen devices compared with insulin vial and syringes in an inpatient setting.

Angela O. Shogbon, Dao Ngo, Bobby Jacob, 2014, Diabetes technology & therapeutics.